Major new funding supports early career investigators working on cures for pancreatic cancer

AGA receives grant from The Bern Schwartz Family Foundation to fund pancreatic cancer research.

2024-02-26

(Press-News.org) Bethesda, MD (Feb. 26, 2024) — The AGA Research Foundation has announced a $1.4 million endowment grant from The Bern Schwartz Family Foundation. The AGA Institute will provide matching support, resulting in a $2.8 million endowment dedicated to advancing basic research in pancreatic cancer, the third leading cause of cancer deaths in the U.S.

The endowment will fund a second AGA-Bern Schwartz Family Fund Research Scholar Award in Pancreatic Cancer. The first award, created in 2013, will also continue. Both awards provide selected early career-investigators with $100,000 per year for three years to have protected time to focus on pancreatic cancer research. The award is named in honor of the late businessman and photographer, Bern Schwartz (1914-1978) who died from the disease.

Over the last two decades six researchers have received this prestigious award:

Kenneth Yu, MD, Memorial Sloan Kettering Cancer Center

Kenneth Olive, PhD, Columbia University Herbert Irving Comprehensive Cancer Center

Laura D. Wood, MD, PhD, Johns Hopkins University School of Medicine

Florencia McAllister, MD, The University of Texas MD Anderson Cancer Center

Jason R. Pitarresi, PhD, UMass Chan Medical School

Srinivas Gaddam, MD, MPH, Cedars-Sinai

“We believe that progress toward a cure for pancreatic cancer will come from the concentrated efforts of smart investigators who have the resources they need and enough dedicated time to do their work,” said Michael Camilleri, MD, DSc, AGAF, chair of the AGA Research Foundation. “We warmly thank The Bern Schwartz Family Foundation for their commitment to continuing this research.”

The Schwartz family added, “The AGA Research Foundation recognizes the critical need for young research talent that is focused on this area, and we are delighted to be their partner in creating a second Research Scholar Award.”

More information

Learn more about AGA Research Foundation.

Learn more about Bern Schwartz and The Bern Schwartz Family Foundation.

Donate to the AGA Research Foundation.

View all AGA Research Foundation awards.

###

Contact for media: Mara Shapiro, media@gastro.org, 301-329-5709

About the AGA Institute

The American Gastroenterological Association is the trusted voice of the GI community. Founded in 1897, the AGA has grown to more than 16,000 members from around the globe who are involved in all aspects of the science, practice and advancement of gastroenterology. The AGA Institute administers the practice, research and educational programs of the organization. www.gastro.org

AGA is on Instagram.
Like AGA on Facebook.
Follow us on X @AmerGastroAssn
Check out our videos on YouTube.
Join AGA on LinkedIn.

About the AGA Research Foundation

The AGA Research Foundation is the cornerstone of AGA’s effort to expand digestive disease research funding. Since 1984, AGA, through its foundation, has provided more than $67 million in research grants to 1,263 scientists. The AGA Research Foundation serves as a bridge to the future of research in gastroenterology and hepatology by providing critical funding to advance the careers of talented researchers between the end of training and the establishment of credentials that earn National Institutes of Health grants. Learn more about the AGA Research Foundation or make a contribution at foundation.gastro.org.

About The Bern Schwartz Family Foundation

The Bern Schwartz Family Foundation sponsors photography exhibitions and educational initiatives in museums, libraries, and universities. Following a successful career in business, Bern Schwartz developed his photography skills and became a world-renowned portrait photographer. His portraits of British royalty, actors and politicians are in the permanent collection of the National Portrait Gallery, London. His photography archive is at the Bodleian Libraries, University of Oxford. His portraits have been exhibited in museums and galleries in the US and Europe. https://bernschwartz.org

END

ELSE PRESS RELEASES FROM THIS DATE:

Poison center calls for ‘magic mushrooms’ spiked after decriminalization, study finds

2024-02-26

Calls to U.S. poison centers involving psilocybin, or “magic mushrooms,” among adolescents and young adults rose sharply after several U.S. cities and states began decriminalizing the hallucinogen, University of Virginia School of Medicine researchers have found. Psilocybin-related calls more than tripled among teens ages 13-19 from 152 to 464 and more than doubled among adults ages 20-25 from 125 to 294 between 2018 and 2022, according to anonymized data gathered from the National Poison Data System. Local and state efforts to decriminalize the possession, use and cultivation of psilocybin began in May 2019. Oregon and Colorado have decriminalized psilocybin, as ...

Researchers overestimate their own honesty

2024-02-26

The average researcher thinks they are better than their colleagues at following good research practice. They also think that their own research field is better than other research fields at following good research practice. This is shown in a new study by researchers at Linköping University, Sweden. The results point to a risk of becoming blind to one’s own shortcomings, according to the Linköping researchers. “The starting point for the project is that there’s a bit of a crisis in the research world. Research misconduct or difficulties to replicate research results have been discovered in many studies. Credibility has been called into question,” ...

Tattoo inks don’t match the ingredients listed on the bottle

2024-02-26

When you get a tattoo, do you know what you’re putting under your skin? According to new Binghamton University research, the ingredient labels on tattoo ink don’t match the actual substances in the bottle. Produced by the lab of Binghamton Univerity Assistant Professor of Chemistry John Swierk, “What’s in my ink: An analysis of commercial tattoo ink on the U.S. market” was recently published in the journal Analytical Chemistry. Swierk’s lab explores the potential impact of light on tattoos and their chemical breakdown. Early on, doctoral student Kelli Moseman ...

May I have a quick word? Study shows talking faster is linked to better brain health as we age

2024-02-26

As we get older, we may start to notice it takes us longer to find the right words. This can lead to concerns about cognitive decline and dementia. However, a new study by Baycrest and the University of Toronto suggests that talking speed is a more important indicator of brain health than difficulty finding words, which appears to be a normal part of aging. This is one of the first studies to look at both differences in natural speech and brain health among healthy adults. “Our results indicate that changes in general talking speed may reflect changes in the brain,” says Dr. Jed Meltzer, ...

Vanishing forests and suffering children: The hidden toll of deforestation in Cambodia

2024-02-26

Deforestation, a critical consequence of human activity, has garnered significant attention due to its impact on environmental sustainability, biodiversity and climate change. However, an equally pressing yet less explored aspect is the relationship between deforestation and human health, especially in impoverished regions. Scientists have increasingly recognized the detrimental effects of deforestation on various aspects of human health, particularly among children. Studies reveal that children residing in areas with high deforestation rates are at an elevated risk of malaria, ...

Birth outcomes improve in states that extend driver’s licenses to undocumented immigrants, research finds

2024-02-26

In 2023, Rhode Island, Massachusetts and Minnesota joined a growing list of states that allow undocumented immigrants to obtain driver’s licenses if an applicant can provide certain documentation, such as a foreign birth certificate or passport and evidence of current residency in the state. Altogether, 19 states and the District of Columbia have similar legislation in place. And lawmakers in other states, such as Michigan and Oklahoma, have introduced similar legislation. In many cases, these laws were passed ...

First-in-humans discovery reveals brain chemicals at work influencing social behavior

2024-02-26

In a study in today’s (Monday Feb. 26) Nature Human Behavior, scientists delve into the world of chemical neuromodulators in the human brain, specifically dopamine and serotonin, to reveal their role in social behavior. The research, conducted in Parkinson's disease patients undergoing brain surgery while awake, homed in on the brain’s substantia nigra, a crucial area associated with motor control and reward processing. Led by Virginia Tech computational neuroscientist Read Montague, the international team revealed ...

Shifting focus: Investigators describe changes to pancreatic β cell at onset of Type 1 Diabetes

2024-02-26

BOSTON – About eight million people live with Type 1 diabetes (T1D) worldwide, a chronic autoimmune condition in which the body attacks and destroys its own insulin-producing β-cells (pronounced “beta”) in the pancreas, leading to a lack of insulin and inability to regulate blood sugar. It’s not known why the body suddenly perceives its own β-cells as the enemy; some lines of evidence suggest environmental factors such as viral infections may trigger the onset of T1D, others suggest genetics may also play some role. Groundbreaking ...

Award-winning researcher dreams of stellar explosions and strives for equity and inclusion in academia

2024-02-26

She studies the giant explosions of dying stars and dreams of experiencing and extracting data from a supernova close to Earth. Professor Irene Tamborra from the Niels Bohr Institute also tirelessly promotes equity and inclusion in research. Today she receives the prestigious Elite Research Prize and DKK 1.2 million in honor of her research in astrophysics. "I am fascinated by anything that explodes in the sky," Professor Irene Tamborra says as she begins to describe her research. The professor from the University of Copenhagen’s ...

Clinical trial tests combination antibody therapy in adults with advanced cancer

2024-02-26

In an early phase clinical trial, a combination of antibody-based medications targeting the immune system generated promising safety data and anti-tumor activity in individuals with various types of advanced cancer. The findings are published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society. Both medications tested in the trial support immune responses against tumor cells. CS1002 increases the activation and proliferation of T immune cells by binding to a T cell receptor called CTLA-4. CS1003, also called nofazinlimab, ...